CSPC Pharmaceutical Group...

OTC: CSPCY · Real-Time Price · USD
5.56
0.15 (2.77%)
At close: Aug 15, 2025, 3:58 PM
5.41
-2.70%
After-hours: Aug 13, 2025, 08:00 PM EDT

CSPC Pharmaceutical Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
9.01B 9.07B 9.24B 9.21B 9.81B 10.01B 9.48B
Depreciation & Amortization
1.77B 1.69B 1.61B 1.58B 1.54B 1.52B 1.42B
Stock-Based Compensation
243.27M 125.09M n/a n/a n/a n/a n/a
Other Working Capital
-1.11B -1.11B n/a n/a n/a n/a n/a
Other Non-Cash Items
-477.06M 1.62B 774.4M 3.39B 3.91B 4.18B 3.19B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-3.66B -2.87B 786.38M -893.45M -1.68B -1.68B n/a
Operating Cash Flow
5.78B 7.42B 9.19B 10.14B 10.5B 10.99B 11.25B
Capital Expenditures
-2.61B -3.61B -3.72B -3.99B -3.13B -2.77B -2.59B
Cash Acquisitions
442.6M 414.48M 184.32M -198.38M 40.35M 620.44M -102.44M
Purchase of Investments
-4.56B -6.08B -11.38B -9.15B -12.24B -11.6B -9.88B
Sales Maturities Of Investments
6.72B 9.21B 9.48B 7.65B 8.16B 10.86B 7.75B
Other Investing Acitivies
-1.06B 466.66M -181M 86.05M 15.65M 14.91M -49.96M
Investing Cash Flow
-1.23B 230.84M -5.62B -5.6B -7.15B -2.87B -4.87B
Debt Repayment
-167.91M -81.99M 238.58M 320.58M 126.14M -194.43M -238.32M
Common Stock Repurchased
-806.16M -452.1M -222.49M -332.07M -333.14M -318.94M -0.49
Dividend Paid
-4.31B -3.76B -3.29B -3.01B -3.1B -3.79B -2.82B
Other Financial Acitivies
32.75M 326.77M 24.89M -104.42M -124.77M -104.43M 159.79M
Financial Cash Flow
-5.01B -3.79B -3.34B -3.23B -3.45B -4.49B -2.97B
Net Cash Flow
8.8B 2.13B -52.56M 1.84B 2.08B 4.76B 4.9B
Free Cash Flow
3.17B 3.81B 5.47B 6.15B 7.38B 8.22B 8.66B